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The establishment of a specific nucleoprotein structure, the telomere, is required to ensure
the protection of chromosome ends from being recognized as DNA damage sites.Telomere
shortening below a critical length triggers a DNA damage response that leads to replica-
tive senescence. In normal human somatic cells, characterized by telomere shortening with
each cell division, telomere uncapping is a regulated process associated with cell turnover.
Nevertheless, telomere dysfunction has also been associated with genomic instability, cell
transformation, and cancer. Despite the essential role telomeres play in chromosome pro-
tection and in tumorigenesis, our knowledge of the chromatin structure involved in telomere
maintenance is still limited. Here we review the recent findings on chromatin modifications
associated with the dynamic changes of telomeres from protected to deprotected state
and their role in telomere functions.
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INTRODUCTION
The linear chromosomes of eukaryotes end with a specific nucle-
oprotein structure, named the telomere (Blackburn, 1991). In
humans, telomeres consist of thousands of repeats of a six-base-
pair motif (5′-TTAGGG-3′) ending in a G-rich 3′-overhang 30–
300 nt long (Makarov et al., 1997), associated with a complex of
six proteins named shelterin (de Lange, 2005). This structure pre-
vents chromosome ends from being recognized as DNA double-
strand breaks and therefore being processed by the DNA repair
machinery. Due to the inability of DNA polymerases to com-
pletely replicate linear genomes – the so-called “end-replication
problem” (Watson, 1972; Olovnikov, 2005) – cells undergo telom-
ere shortening at every replication round. The loss of terminal
DNA is counteracted by the activity of the telomerase enzyme,
which adds de novo telomeric repeats to the G-rich 3′-overhang
(Blackburn, 2005). In humans, telomerase is active only in germ
line and in stem cells, but not in somatic cells where telomeres
shorten till they reach a critical length that activates a DNA damage
response (DDR) leading to replicative senescence or to apoptosis
(Shay and Wright, 2005). This limit to the number of cell divi-
sions constitutes an important barrier against cancer proliferation,
because it reduces the risk of accumulating harmful mutations
that could lead to malignant transformation. On the other hand,
if cells escape p53 and Rb-dependent DNA damage checkpoints,
telomere erosion could result in high chromosomal instability and
facilitate the generation of tumor-promoting mutations (Artandi
and DePinho, 2010). The re-activation of telomerase after these
events stabilizes the genome and favors the establishment of malig-
nant transformation. Besides its involvement in cancer, replicative
senescence contributes to the physiology of aging and to the devel-
opment of age-related diseases (Shay and Wright, 2005; Armanios
and Blackburn, 2012).
Given the importance of telomeres in cancer establishment
and in aging, the understanding of how protected and unpro-
tected telomeres are structured is a very important issue in basic
research. In this article we will examine the current knowledge
regarding telomere structure and analyze the role of nucleo-
somes and chromatin organization in determining chromosome
end-protection.
THE DYNAMIC STRUCTURE OF TELOMERES
Telomeres are extremely dynamic structures: in order to accom-
plish their multiple tasks their organization has to switch between
a protected and a deprotected state throughout the cell cycle and
cell differentiation (Blackburn, 2001).
During the cell cycle, telomere structure has to change from a
closed conformation concealing chromosome ends from repairing
enzymes, to an open one in S-phase in order to allow controlled
access to DNA replication factors. A dramatic change occurs in
telomerase negative cells as a consequence of telomere shortening.
When they reach a critical short length, telomeres uncap triggering
an ataxia telangiectasia mutated (ATM) and/or ataxia telangiecta-
sia and Rad3 related (ATR) signaling cascade (d’Adda di Fagagna
et al., 2003), that eventually leads to a p53-dependent cell cycle
arrest or to apoptosis (Harley et al., 1990; Herbig et al., 2004).
The nature of telomere structure in protected and deprotected
states has not been completely clarified. Capping requires the bind-
ing of specific proteins that recognize telomeric DNA and shield
single-stranded G-overhangs by hiding them into specific struc-
tures. An attractive solution, although not necessarily exclusive, to
the end capping dilemma is represented by the telomeric loop, or
t-loop (de Lange, 2004). T-loops have been identified by electron
microscopy visualizations of purified telomeric DNA treated with
the cross-linking agent psoralen (Griffith et al., 1999). In these
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lasso-like structures, the 3′-overhang folds back and invades the
upstream telomeric region, generating a displacement loop (D-
loop). T-loops are very variable in size and have been found in
several eukaryotes (Tomaska et al., 2004), although it is not clear
whether they are present at all telomeres (de Lange, 2004). An alter-
native structure capable of sheltering the free chromosome ends
is a four-stranded DNA structure named G-quadruplex (Sen and
Gilbert, 1988), which derives from the folding of single-stranded
DNA containing runs of three to four consecutive guanines to form
stacked tetrads of Gs, stabilized by Hoogsteen hydrogen bond-
ing and cation coordination. Although in vitro telomeric G-rich
single-stranded DNAs form very stable G-quadruplex structures
easily, their existence in vivo is controversial (Lipps and Rhodes,
2009). Several proteins are able to bind to, cleave, resolve, or
promote the formation of telomeric G-quadruplexes from sev-
eral species in vitro (Oganesian and Bryan, 2007). In addition,
a synthetic small molecule was shown to mediate the selective
isolation of human telomeric DNA, containing G-quadruplex
motifs, from human cells (Muller et al., 2010). The first evidence
of the in vivo formation of G-quadruplexes has been obtained
in ciliates (Paeschke et al., 2005), by using specific antibodies
against the G-quadruplex structure. In mammals, indirect proofs
of G-quadruplex formation came from several studies that used
G-quadruplex stabilizing molecules as telomerase inhibitors in
anticancer strategies (De Cian et al., 2008; Micheli et al., 2009;
Bryan and Baumann, 2011). Very recently, using a highly spe-
cific DNA G-quadruplex antibody, these structures have been
visualized in human cells (Biffi et al., 2013). Interestingly, the
formation of G-quadruplexes increased during S-phase. T-loop
and G-quadruplex represent two possible solutions to the end-
protection problem and could embody different functional states
at telomeres. Interestingly, both structures need the activity of
the RTEL1 helicase in order to be resolved and allow an efficient
telomere replication (Vannier et al., 2012).
However,other structural solutions to the end-protection prob-
lem have been recently described. 5′-C-overhangs have been
recently discovered in Caenorhabditis elegans, where they are as
abundant as G-overhangs (Raices et al., 2008), and have been also
found in mouse and human cells (Oganesian and Karlseder, 2011).
C-overhangs are present at low frequency in primary cells, whereas
they are enriched in cells that have established a telomerase-
independent mechanism of telomere maintenance named ALT
(alternative lengthening of telomeres), based on recombination
(Bryan et al., 1997). Another structural solution has been recently
identified in Arabidopsis thaliana. In this plant, telomeres deriv-
ing from leading strand replication are not processed to gener-
ate 3′ G-overhangs, but are conserved as blunt-ended telomeres
(Kazda et al., 2012). Their protection depends on the Ku70/Ku80
heterodimer, a complex involved in DNA repair activities. Inter-
estingly, Ku-depleted telomeres are still functional, suggesting
the existence of several alternative structures able to protect
chromosome ends.
SHELTERIN AND FRIENDS: A LOT OF PLAYERS AT THE END
OF CHROMOSOMES
Telomeric DNA interacts with several factors to accomplish its
tasks. Extensive research has been devoted to understand the
functions carried out by the specific proteins that form the pro-
tective complex at telomeres, known in mammals as the shelterin
complex. Less clear is the role played by nucleosomes, although
they organize most of telomeric chromatin. Also the functions of
TERRA, the recently discovered non-coding RNAs transcribed at
the telomeres, are not yet understood.
SHELTERIN
In mammals, the shelterin complex is composed of six proteins,
TTAGGG repeat binding factors 1 and 2 (TRF1, TRF2), protec-
tion of telomeres 1 (POT1), repressor/activator protein 1 (RAP1),
TRF1-interacting nuclear factor 2 (TIN2), and TIN2-interacting
protein 1 (TPP1) (for a review, see Palm and de Lange, 2008;
Diotti and Loayza, 2011). Double-stranded telomeric repeats are
bound by TRF1 and TRF2, whereas the single-stranded overhang
is bound by POT1, which forms a heterodimer with TPP1. RAP1
interacts in a 1:1 ratio with TRF2; the sixth member of shelterin,
TIN2 connects TRF1 and TRF2 with the heterodimer TPP1/POT1.
Shelterin acts by inhibiting DDR pathways at telomeres. Deletion
of each individual shelterin protein causes destabilization of the
capping structure in a way that resembles spontaneous telom-
ere deprotection consequent to extreme telomere erosion. Even if
the shelterin complex represents a functional unit, specific func-
tions can be attributed to individual shelterin components. The
ATM kinase pathway is repressed by TRF2 (Celli and de Lange,
2005; Denchi and de Lange, 2007). TRF2 depletion results in
the accumulation at telomeres of DDR factors such as γ-H2AX,
53BP1, mediator of DNA damage checkpoint 1 (MDC1) (Takai
et al., 2003) forming DNA damage foci called TIFs (Telomere
dysfunction-Induced DNA damage Foci). Instead, activation of
the ATR signaling pathway requires the removal of POT1 (Denchi
and de Lange, 2007). TRF2 and POT1 are also key players in pre-
venting two major DNA repair activities, Non-Homologous End-
Joining (NHEJ) and Homology Directed Repair (HDR) (de Lange,
2009). Removal of the entire shelterin complex from mouse telom-
eres revealed protection from two other DDR pathways, alternative
NHEJ (alt-NHEJ) and resection (Sfeir and de Lange, 2012).
The shelterin proteins are also involved, either directly or indi-
rectly by recruiting accessory factors, in regulating telomerase
activity and access to chromosome ends (Wang et al., 2007; Bau-
mann and Price, 2010), allowing the correct replication of the
telomeric duplex (Sfeir et al., 2009), promoting the generation and
maintenance of G-overhangs (Zhu et al., 2003; Wu et al., 2010),
affecting telomere topology (Amiard et al., 2007), and favoring t-
loop formation (Stansel et al., 2001; Poulet et al., 2009). A list of
proteins that interact with shelterin and their known function at
telomeres is reported in Table 1.
Since telomeric sequences are highly evolutionarily conserved,
it is not surprising that shelterin homologs have been character-
ized in several species. In fission yeast, double-stranded telomeric
DNA is bound by TAZ1, a TRF1/TRF2 ortholog (Cooper et al.,
1997), whereas the single-stranded binding protein POT1 forms
a complex with TPZ1, a homolog of TPP1 (Miyoshi et al., 2008).
In Saccharomyces cerevisiae, RAP1 binds directly to the telomeric
double-stranded repeats (Gilson et al., 1993), whereas the CST
(Cdc13/Stn1/Ten1) complex binds the single-stranded DNA (for a
review of yeast telomeres; Wellinger and Zakian, 2012). Drosophila
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Table 1 | Proteins that interact with telomeric DNA and shelterin components.
Protein Org. Binding partners Function(s) Reference
CST h Tel-DNA, POT1-TPP1 Inhibition of telomerase activity Chen et al. (2012)
MRE11, RAD50,
NBS1
h, m TRF2, TRF1 DDR; 3′-overhang generation Wu et al. (2000, 2007a), Zhu et al. (2000),
Misri et al. (2008), Deng et al. (2009a)
ATM h TRF2 Role in DDR Karlseder et al. (2004)
Rad9 h TRF2, Rad51 DDR; role in HR Pandita et al. (2006)
WRN h Tel-DNA, TRF1, TRF2,
POT1, Ku70/80, BLM
DNA replication; resolution of secondary
structures; inhibition of telomere circle formation
Opresko et al. (2004, 2005), Li et al. (2008)
FEN1 h TRF2, WRN Telomere replication Saharia et al. (2008, 2010)
PINX1 h TERT; recruited by TRF1 Inhibition of telomerase activity Zhou and Lu (2001)
GNL3L h TRF1 TRF1 homodimerization and stabilization Zhu et al. (2009)
NS m, h TRF1 TRF1 turnover Zhu et al. (2006)
PIN1 h, m TRF1 (phosphoT149) TRF1 turnover Lee et al. (2009)
Fbx4 h TRF1 TRF1 turnover Lee et al. (2006)
Apollo h, m Tel-DNA; recruited by TRF2 3′-Overhang maintenance Freibaum and Counter (2006), Lenain et al.
(2006), Lam et al. (2010), Wu et al. (2010)
PNUTS h Recruited by TRF2 Possible role in DDR Kim et al. (2009), Landsverk et al. (2010)
MCPH1 (BRIT1) h Recruited by TRF2 Possible role in DDR Kim et al. (2009), Lin et al. (2010)
Ku70/80 h, m TRF1, TRF2 Telomere protection from deletions and HDR Hsu et al. (2000), Celli et al. (2006), Wang
et al. (2009)
DNA-PKcs m Tel-DNA Telomere capping d’Adda di Fagagna et al. (2001), Gilley et al.
(2001)
ATRX h Tel-DNA Incorporation of H3.3 at telomeres Law et al. (2010)
CSB h TRF2 Telomere stability; TERRA homeostasis Batenburg et al. (2012)
TRIP6, LPP h TRF2, TIN2, probably POT1 Possible DDR inhibition Sheppard and Loayza (2010)
HP1γ h TIN2 Maintenance of telomere cohesion Canudas et al. (2011)
RTEL1 m nd T-loop disassembling; G4-DNA unwinding;
prevention of telomere fragility
Vannier et al. (2012)
BLM h TRF1, TRF2, WRN G4-DNA unwinding; resolution of late-replicating
structures
Sun et al. (1998), von Kobbe et al. (2002),
Barefield and Karlseder (2012)
SIRT1 m Tel-DNA, Nbs1, WRN Promotion of HR; TL Palacios et al. (2010)
Tankyrase 1 h TRF1, DNA-PKcs T-SCE suppression and DNA-PKcs stabilization Dregalla et al. (2010)
org, organism; h, human; m, mouse; nd, not determined; tel-DNA, telomeric DNA; DDR, DNA damage response; HR, homologous recombination; NHEJ, non-
homologous end-joining; HDR, homology directed repair; TERRA, telomeric repeat containing RNA; G4-DNA, G-quadruplex DNA; TL, telomere lengthening; T-SCE,
telomere sister chromatid exchanges.
represents an exception to the evolutionarily conserved organiza-
tion of telomeres. InDrosophila telomerase is absent and telomeres
consist of transposable elements (Mason et al., 2008); end capping
is independent from DNA sequence and is assured by the pro-
tein complex named terminin, that includes at least four proteins:
HOAP, HipHop, Modigliani (Moi), and Verrocchio (Ver) (Raffa
et al., 2011). Terminin proteins are not conserved outside the
Drosophilidae, with the exception of Ver, which exhibits structural
homology with Stn1 (Raffa et al., 2010).
TELOMERIC RNA
Since their discovery and characterization, telomeres have been
considered transcriptionally silent chromosomal regions. The
spreading of the heterochromatic state from the telomeres toward
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the subtelomeric regions causes transcriptional repression of
nearby genes or telomere position effect (TPE) (Gottschling et al.,
1990; Koering et al., 2002; Ottaviani et al., 2008). This concept
changed with the discovery that telomeres are transcribed into long
non-coding RNAs (Azzalin et al., 2007). These telomeric repeat
containing RNAs, named TERRA, have been found in several
eukaryotic species, from yeast to mammals (Schoeftner and Blasco,
2008; Bah et al., 2012; Greenwood and Cooper, 2012). TERRA are
transcribed mainly by RNA Polymerase II, starting from subtelom-
eric promoters that have been partially identified in human cells
(Nergadze et al., 2009). The role of TERRA in telomere capping
remains elusive. In yeast TERRA negatively affects telomere length
(Maicher et al., 2012; Pfeiffer and Lingner, 2012). A relationship
between TERRA transcription and telomere length has been found
also in human cells, where TERRA levels seem to be negatively
regulated by telomere elongation through the increase of hete-
rochromatic marks at telomeres (Arnoult et al., 2012). Although
in vitro experiments suggest that TERRA levels negatively affect
telomerase activity (Redon et al., 2010), recent findings show that
telomere homeostasis is independent of telomere transcription
(Farnung et al., 2012).
TELOMERIC NUCLEOSOMES
Similarly to the rest of chromosomal DNA, the long telomeres
of higher eukaryotes are organized in nucleosomes (Pisano et al.,
2008). Nucleosomes derive from the wrapping of 147 bp of DNA
around a globular basic protein complex, the histone octamer.
Not only nucleosomes represent a way for eukaryotes to pack
their abundant DNA content in their small nuclear volume, but
they are also a key factor in the regulation of several biological
processes (Luger, 2006). Most telomeric DNA is organized in an
unusual chromatin structure, characterized by regularly spaced
and tightly packed nucleosomes separated by DNA linkers about
40 bp shorter than in bulk DNA (Makarov et al., 1993; Tommerup
et al., 1994; Fajkus et al., 1995; Lejnine et al., 1995). This peculiar
organization is likely to reflect both the interplay with telomeric
proteins and the intrinsic properties of telomeric sequences. DNA
sequence plays an important role in determining several features
of nucleosomes, such as thermodynamic stability and position-
ing, dictating which DNA tracts directly interact with the histone
octamer. The wrapping of DNA around the histone octamer is
ruled by intrinsic features such as DNA flexibility and stiffness
(Anselmi et al., 2000; Filesi et al., 2000). Since telomeric repeats
(mostly 5–8 bp long) are out of phase with the DNA helical repeat
in the nucleosome (10.2 bp), it has been suggested that telomeric
DNAs may require more energy that the remaining genomic DNA
to wind around the histone octamer (Fajkus et al., 1995; Pisano
et al., 2008). In line with this hypothesis, in vitro reconstitution
studies showed that telomeric DNAs form the least stable nucle-
osomes among all the DNA sequences studied so far (Cacchione
et al., 1997; Rossetti et al., 1998; Filesi et al., 2000). Moreover,
telomeric nucleosomes can occupy multiple isoenergetic posi-
tions (Rossetti et al., 1998; Filesi et al., 2000), i.e., they form with
the same probability on several positions along telomeric DNA.
The lack of positioning signals implies that the energy required
for the histone octamer to slide from one position to another
along the telomeric DNA is low (Filesi et al., 2000); therefore,
telomeric nucleosomes are highly intrinsically mobile in vitro at
physiological ionic strengths, as shown by atomic force microscopy
(AFM) imaging (Pisano et al., 2007). Sequence-dependent features
are also a major determinant of nucleosome spacing at telom-
eres. AFM visualizations of in vitro assembled nucleosomal arrays
demonstrated that at low histone octamer/DNA ratios (about
one nucleosome every 300–400 bp) the spacing between telom-
eric nucleosomes is irregular, whereas at saturating histone/DNA
ratios the inter-nucleosomal distance is comparable to the value
found in vivo (Mechelli et al., 2004; Pisano et al., 2006). A regular
and short nucleosomal spacing has been reported also by in vitro
assembly at near-physiological conditions (Galati et al., 2012). In
their experiments the authors used Drosophila embryonic extracts
to assemble a nucleosomal array in the presence of histone chap-
erones and chromatin remodeling complexes. Whereas the nucle-
osomal repeat length is about 200 bp in arrays reconstituted on
different control DNAs, in the case of telomeric DNA the repeat
length was about 160 bp, strongly indicating that the short nucleo-
somal spacing is an intrinsic feature of telomeric sequences (Galati
et al., 2012).
Little is known about the higher order organization of telom-
eric chromatin. The linker histone H1, normally present at 1:1
H1/histone octamer ratio in bulk chromatin, seems to be under-
represented at telomeres (Bedoyan et al., 1996; Dejardin and
Kingston, 2009). Moreover, the short nucleosomal spacing sug-
gests that higher order chromatin condensation would be peculiar.
Different models have been proposed, ranging from a narrow
columnar packaging (Fajkus and Trifonov, 2001) to a nucleo-
somal folding in which diameter of the fiber (ranging from 25
to 30 nm) and angles between nucleosomes are dictated by the
length of linker DNA (Besker et al., 2003). Consistent with the
latter model, electron microscopy images of chromatin fractions
enriched in telomeric chromatin from differentiated tissues such as
chicken erythrocytes and mouse lymphocytes, showed that telom-
eres are organized in a fiber of about 30 nm diameter (Nikitina
and Woodcock, 2004).
A TELOMERIC HISTONE CODE?
Histone post-translational modifications and histone variants play
a key role in the regulation of most cellular processes, includ-
ing transcription, DNA repair, and recombination. Numerous
post-translational modifications have been found associated with
telomeric regions (reported in Table 2), and various factors have
been shown to influence the organization of telomeric chromatin
(see Table 3). Telomeric chromatin has been generally consid-
ered as “heterochromatic,” mainly on the basis of extensive studies
on yeast and Drosophila telomeres, in which the establishment of
a heterochromatic state at telomeres and subtelomeres is essen-
tial for the protection of chromosome ends (Shore, 2001; Raffa
et al., 2011). In budding yeast telomeres are short and form a
nucleosome-free structure (Wright et al., 1992). Telomeric double-
stranded repeats are bound by the protein RAP1 which recruits
among other proteins the Sir complex [Silent Information Regu-
lators, Sir2 (a histone deacetylase), Sir3, and Sir4]. The Sir complex
is essential for the formation of a heterochromatic complex that
spreads in the subtelomeric region, giving rise to the repression of
nearby genes (Ottaviani et al., 2008).
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Table 2 | Post-translational modifications (PTM) at telomeres.
Modification target Org. PTM type Responsible enzyme Function(s) Reference
H3K9 m Methylation SUV39H1, SUV39H2 Chromatin compaction Blasco (2007)
H4K20 m Methylation SUV4-20H1, SUV4-20H2 Chromatin compaction Blasco (2007)
H3K79 m Methylation Dot1L Chromatin compaction Jones et al. (2008)
H2BK5, H3K4 h Methylation nd nd Rosenfeld et al. (2009)
H3K9 At Methylation nd nd Vrbsky et al. (2010)
H3K27, H3K4 At Methylation nd nd Vrbsky et al. (2010),
Vaquero-Sedas et al.
(2012)
H2AX h Phosphorylation ATM, ATR, DNA-PKcs DDR signaling Takai et al. (2003)
H2A, H2AX m Ubiquitylation RNF8 DDR signaling Peuscher and Jacobs
(2011), Jacobs (2012)
H2A, H2AX m, h Ubiquitylation RNF168 Recruitment of 53BP1; NHEJ signaling Doil et al. (2009),
Okamoto et al. (2013)
H4K12 Sc Acetylation NuA4 Regulation of chromatin plasticity and
accessibility
Zhou et al. (2011)
H3K9 At Acetylation nd nd Vaquero-Sedas et al.
(2012)
H3K9ac, H3K56ac h Deacetylation SIRT6 Chromatin compaction Michishita et al. (2008),
reviewed in Tennen and
Chua (2011)
H3K9ac m Deacetylation SIRT1 Chromatin compaction Palacios et al. (2010)
TRF1 h Ubiquitylation Fbx4, RLIM TRF1 turnover Chang et al. (2003), Her
and Chung (2009)
TPP1 m, h Ubiquitylation RNF8 TPP1 stabilization; A-NHEJ repression Rai et al. (2011)
TRF2 h Ubiquitylation Siah1 TRF1 turnover, induced by p53 Fujita et al. (2010)




TRF1 h Poly-ADP-ribosylation Tankyrase (1 and 2) Decrease of TRF1 affinity for the DNA;
TRF1 proteasomal degradation; TL
Smith and de Lange
(2000), Cook et al.
(2002), Dynek and
Smith (2004)
Ub-TRF1 m, h Deubiquitylation USP22 TRF1 turnover; stabilization of WRN
telomere association
Atanassov et al. (2009)
TRF1, TRF2 m, h Sumoylation SMC5/6 HR and TL (in ALT cells) Potts and Yu (2007)
TRF2 h Methylation PRMT1 Telomere stability; telomere length
regulation
Mitchell et al. (2009)
TRF2 h Phosphorylation Aurora C*, ATM, CHK2 Decrease of TRF2 binding to telomere Tanaka et al. (2005),
Spengler (2007),
Buscemi et al. (2009)
TRF1 h Phosphorylation Plk1, CK2 Increase of telomere binding; role in
TRF1 expression-induced apoptosis; TS
Kim et al. (2008), Wu
et al. (2008)
(Continued)
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Table 2 | Continued
Modification target Org. PTM type Responsible enzyme Function(s) Reference
TRF1 h Phosphorylation ATM, Cdk1 Decrease of TRF1 binding to telomere;
TL
Wu et al. (2007a),
McKerlie and Zhu
(2011), McKerlie et al.
(2012)
TRF1 h Phosphorylation Akt* TS Chen et al. (2009)
Cdc13 Sc Sumoylation Siz1, Siz2 Telomerase inhibition Hang et al. (2011)
Yku70/80, Sir4 Sc Sumoylation Siz2 Anchoring at NE, preventing TL Ferreira et al. (2011)
TERT h Ubiquitylation MKRN1, Hdm2, CHIP TERT proteasomal degradation; TS Kim et al. (2005), Lee
et al. (2010), Oh et al.
(2010)
TERT h Phosphorylation Tyrosine kinase c-Abl Inhibition of TERT activity; TS Kharbanda et al. (2000)




Gonzalo et al. (2006)
nd m Phosphorylation DNA-PKcs Telomere protection Bailey et al. (2004),
Williams et al. (2009)
nd Sc Ubiquitylation Cul8 Transcriptional silencing Mimura et al. (2010)
org, organism; m, mouse; h, human; At, Arabidopsis thaliana; Sc, Saccharomyces cerevisiae; nd, not determined; ∗, in vitro evidences; DDR, DNA damage response;
A-NHEJ, alternative non-homologous end-joining; TL, telomere lengthening; HR, homologous recombination; TS, telomere shortening; NE, nuclear envelope.
Drosophila telomeres are enriched in histone marks such as
trimethylation of Lys 9 of the H3 histone (H3K9me3). This his-
tone mark is recognized by heterochromatin protein 1 (HP1), an
essential factor for the protection of Drosophila telomeres (Fanti
et al., 1998) and for the spreading of heterochromatin through
the recruitment of the histone methyltransferase (HMTase) SU-
VAR3-9 (Schotta et al., 2002).
Heterochromatin formation has an important function also
for telomere capping in Schizosaccharomyces pombe. In this organ-
ism, telomere protection is assured by a complex of shelterin-
like proteins (Moser and Nakamura, 2009). In the absence of
telomerase, S. pombe cells can survive telomere loss by adopt-
ing an alternative mode to protect chromosome ends based on
amplification and rearrangement of heterochromatic regions (Jain
et al., 2010). In these survivors, named HAATI (heterochromatin
amplification-mediated and telomerase-independent), the telom-
eric 3′-overhang still binds the protein POT1 and its interacting
partner Ccq1 (Miyoshi et al., 2008), which is known to bind also
the heterochromatic complex Snf2/HDAC-containing repressor
complex (SHREC) (Sugiyama et al., 2007). These data suggest
that heterochromatin could recruit POT1 to telomeres via the
Ccq1/SHREC complex, allowing POT1 binding to chromosome
ends even in the absence of its specific recognition sequences (Jain
et al., 2010). These particular telomeres in S. pombe resemble
Drosophila telomeres, that lack specific sequence recognition by
telomeric proteins (Raffa et al., 2011).
EPIGENETIC STATE OF TELOMERES IN PLANTS AND MAMMALS
The epigenetic state of organisms with long telomeres such as
higher plants and mammals is much less definite. This is partly
due to the difficulty of obtaining clear results from ChIP analyses.
The hybridization with a telomeric probe does not allow distin-
guishing between real terminal telomeric sequences and telomeric
repeats located at internal sites on the genome, the so-called inter-
nal telomeric sequences (ITSs). ITSs are present at subtelomeric
and internal positions in several plants and vertebrates, includ-
ing humans (Meyne et al., 1990; Azzalin et al., 2001; Lin and Yan,
2008). Analyses of histone marks at ITS and at telomeres have
been recently carried out in Arabidopsis by two different research
groups. The first group used stringent hybridization conditions to
distinguish ITSs from telomeres and found the presence of both
heterochromatic and euchromatic marks at Arabidopsis telomeres
and subtelomeres (Vrbsky et al., 2010). The second group used the
restriction enzyme Tru9I to distinguish between ITS and telom-
eric repeats. Tru9I cuts most interspersed ITSs with a recognition
motif 5′-TTAA-3′, leaving intact the telomeric 5′-TTTAGGG-3′
repeats.Arabidopsis subtelomeric regions and ITSs result enriched
in heterochromatic marks whereas telomeres exhibit euchromatic
features such as H3K9 and H4K16 acetylation (Vaquero-Sedas
et al., 2011). A later work by the same research group addressed
the epigenetic state of Arabidopsis telomeres and centromeres by
ChIP-sequence analysis (Vaquero-Sedas et al., 2012), substantially
confirming the presence of some euchromatic marks at telomeres.
In addition, both subtelomeric and telomeric DNA were methy-
lated in Arabidopsis and tobacco (Cokus et al., 2008; Vrbsky et al.,
2010; Majerova et al., 2011). Altogether, these studies showed a
mix of both euchromatic and heterochromatic marks at plant
telomeres.
In mammals, extensive studies have been carried out in mouse
to characterize the epigenetic marks associated with telomeres and
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Table 3 | Factors influencing telomeric chromatin.
Name Org. Binding partners Function(s) Reference
ORC h Tel-DNA, TERRA;
TRF2
DNA replication; inhibition of telomere
circle formation
Deng et al. (2007, 2009b)
TERRA h TRF1, TRF2, ORC.
HP1, H3K9me3
Facilitation of TRF2-ORC interaction;
chromatin compaction
Deng et al. (2009b)
ERCC1/XPF h, m Tel-DNA 3′-Overhang degradation (in uncapped
telomeres)
Zhu et al. (2003), Munoz et al. (2005),
Wu et al. (2007b)
53BP1 m H4K20me2 Promotion of NHEJ; increase of telomere
mobility (in dysfunctional telomeres)
Dimitrova et al. (2008)
SHREC Sp Ccq1 Regulation of nucleosome positioning;
telomeric silencing
Sugiyama et al. (2007)
14-3-3σ h nd Help in DDR (G2 arrest) Dhar et al. (2000)
DNA-Pkcs h, m WRN B-NHEJ repression; promotion of WRN
helicase activity on D-loop; capping
Gilley et al. (2001), Bombarde et al.
(2010), Kusumoto-Matsuo et al. (2010)




Lachner et al. (2001), Koering et al.
(2002), Garcia-Cao et al. (2004), Perrini
et al. (2004)
Cbx1, Cbx3, Cbx5 m H3K9me3 Chromatin compaction Garcia-Cao et al. (2004)
Daxx/ATRX m H3.3 Deposition of H3.3 Goldberg et al. (2010), Lewis et al. (2010)
ATRX h, m mH2A Inhibition of mH2A1 incorporation; TERRA
repression (m)
Ratnakumar et al. (2012)
Rb1, Rbl1, Rbl2 m HP1, SUV4-20H
HMTases
TS and chromatin compaction Garcia-Cao et al. (2002), Gonzalo and
Blasco (2005)
miR-290 (Dicer-dependent) m Rbl2 mRNA Regulation of DNA methylation Benetti et al. (2008a), Sinkkonen et al.
(2008)
org, organism; h, human; m, mouse; Sp, Schizosaccharomyces pombe; d, Drosophila melanogaster; nd, not determined; tel-DNA, telomeric DNA;TERRA, telomeric
repeat-containing RNA; NHEJ, non-homologous end-joining (B, backup; C, classical); DDR, DNA damage response; TS, telomere shortening.
subtelomeres (Blasco, 2007). ChIP analyses have demonstrated
that both regions were enriched in heterochromatic marks, namely
H3K9me3 and H4K20me3, and were hypoacetylated in H3 and
H4; in addition, subtelomeric DNA was heavily methylated. The
enrichment at telomeres of H3K9me3 and H4K20me3 was con-
firmed by genome-wide mapping of the chromatin state of mouse
embryonic stem (ES) cells, neural progenitor cells, and embry-
onic fibroblasts (Mikkelsen et al., 2007). H3K9me3 is responsible
for the recruitment at telomeres of HP1 proteins (HP1α, HP1β,
and HP1γ) through a high affinity binding site (Lachner et al.,
2001). Similarly to Drosophila, HP1 mouse isoforms promote the
spreading of heterochromatin by interacting with the HMTases
SUV4-20H1/2 that catalyzes the trimethylation of H4K20 (Schotta
et al., 2004). The establishment of a heterochromatic region is
important for the structural integrity of mouse telomeres; knock-
out deletions of HMTases (SUV39H1/2, SUV4-20H1/2) and DNA
methyltransferases (DNMT3A/B, and DNMT1) result in defective
telomere function, aberrantly increased telomere length, and chro-
mosomal instability (Garcia-Cao et al., 2004; Gonzalo et al., 2005,
2006). Also the methylation of another lysine of the H3 histone,
H3K79, by the methyltransferase Dot1, is required for the forma-
tion of a heterochromatic telomere structure (Jones et al., 2008).
Consistent with these observations, deficiency of the deacetylase
Sirt1, a mouse ortholog of yeast Sir2, causes a decrease of het-
erochromatic marks and triggers a DDR at telomeres (Palacios
et al., 2010).
ARE HUMAN TELOMERES HETEROCHROMATIC?
Less clear is the epigenetic state of human telomeres. ChIP exper-
iments indicate that the levels of heterochromatic marks such as
H3K9me3, H4K20me3, and H3K27me3 are unexpectedly low at
telomeres in human fibroblasts (O’Sullivan et al., 2010). A ChIP-
seq analysis of histone marks at non-coding regions of human
CD4+ T-cells showed that telomeres are significantly enriched in
H2BK5me1 and H3K4me3, two post-translational histone mod-
ifications often found associated with actively transcribed genes
(Rosenfeld et al., 2009). H3K9me3 is under-represented at telom-
eres, whereas it is enriched at subtelomeres, although at lower
levels than at centromeric and pericentromeric regions (Rosen-
feld et al., 2009). Another genome-wide analysis addressed the
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chromatin profile of nine different human lines (Ernst et al., 2011).
In this study, the chromatin state of repetitive sequences (there-
fore not only telomeric DNA) resulted enriched in heterochro-
matic marks such as H3K9me3. However, direct evidence that
the establishment of a heterochromatic state at human telomeres
is important for chromosome stability was derived from studies
analyzing the effects of the depletion of SIRT6, a member of the
Sir2 family (also called sirtuins). In yeast, Sir2 promotes the tran-
scriptional silencing at several heterochromatic regions including
subtelomeres (Gottschling et al., 1990), by deacetylating several
lysines on N-terminal histone tails (Imai et al., 2000). SIRT6 is
a Nad+-dependent histone deacetylase that specifically removes
acetyl residues from H3K9 (Michishita et al., 2008) and H3K56
(Michishita et al., 2009) at telomeres. Knockout of human Sirt6
leads to hyperacetylation of H3K9 and H3K56, and has severe con-
sequences on chromosome stability, resulting in telomere fusions
and premature senescence (Michishita et al., 2008), and in the
abrogation of the TPE (Tennen et al., 2011). These data suggest
that the presence of histone marks generally associated with a
heterochromatic state, such as hypoacetylation, is essential for
the protective capping of human telomeres. In agreement with
this, recent data showed that the heterochromatic protein HP1-γ
binds the C-terminal domain of TIN2 and is required for telomere
cohesion during S-phase (Canudas et al., 2011).
Another layer of complexity and flexibility is added by the pres-
ence of histone variants, non-allelic isoforms of the four canonical
histones H2A, H2B, H3, and H4. Histone variants genes are gen-
erally present in single copy in the genome, and are expressed
throughout the cell cycle, whereas canonical histone genes are clus-
tered in repeated arrays and are almost exclusively transcribed dur-
ing the S-phase. Recently, it has been shown that mouse and human
telomeres contain the histone H3 variant H3.3 (Goldberg et al.,
2010; Ratnakumar et al., 2012). H3.3 is enriched within actively
transcribed genes, through a replication-independent deposition
mechanism catalyzed by the histone chaperone HIRA. Instead,
H3.3 deposition at telomeres is mediated by the remodeling com-
plex ATRX in cooperation with the histone chaperone DAXX.
Knockdown of ATRX by RNAi causes telomere dysfunctions in
mouse ES cells (Wong et al., 2010) and up-regulation of TERRA
expression (Goldberg et al., 2010). Interestingly, ATRX is a neg-
ative regulator of the deposition of macroH2A, a H2A variant
abundant in heterochromatic domains such as the inactivated
X chromosome (Ratnakumar et al., 2012). Recently, ATRX and
DAXX mutations have been associated with pancreatic neuroen-
docrine tumors (Heaphy et al., 2011; Jiao et al., 2011) and pediatric
glioblastoma (Schwartzentruber et al., 2012) and with the estab-
lishment of a ALT mechanism of telomere maintenance (Lovejoy
et al., 2012).
The emerging view is that human telomeres are characterized
by a mix of heterochromatic and euchromatic marks, which give
rise to a specific epigenetic pattern with functions and implications
that need to be further elucidated.
CHROMATIN MODIFICATIONS IN DEPROTECTED TELOMERES
The deprotection of the telomeric capped structure,either as a con-
sequence of telomere shortening or due to shelterin dysfunction,
leads to dramatic changes that affect also the epigenetic pattern
and the nucleosomal organization of telomeres. Experiments in
telomerase negative mice (terc−/−) showed that telomere short-
ening correlates with a significant decrease of two heterochromatic
marks at telomeres and subtelomeres, H3K9me3 and H4K20me3,
and with the increase of H3 and H4 acetylation (Benetti et al.,
2007). Moreover, there is a decrease of subtelomeric DNA methy-
lation and of the binding of CBX3 (homolog of the Drosophila
protein HP1) to telomeres and subtelomeres.
Several histone modifications are associated with the DDR con-
sequent to shelterin loss, or to extreme telomere shortening. The
activation of ATM and/or ATR signaling leads to the phosphory-
lation of the histone variant H2AX (γ-H2AX) on its C-terminal
tail (Miller and Jackson, 2012). This modification is not limited
to DNA damage at telomeres, since it represents one of the most
evident modifications following DNA DSBs along the genome,
encompassing an area of about 1 Mb around the site of DNA dam-
age (Iacovoni et al., 2010). γ-H2AX acts recruiting MDC1 (Stucki
et al., 2005) and other factors at the DBS. ATM-phosphorylated
MDC1 in turn recruits RNF8 (Ring Finger Protein 8), an E3
ubiquitin ligase that cooperates with the E2 conjugating enzyme
UBC13 to ubiquitylate histones H2A and H2AX (Mailand et al.,
2007). A second Ring type E3 ubiquitin ligase enzyme, RNF168,
binds ubiquitinylated histones and catalyzes the spreading of his-
tone ubiquitylation around the DNA damage site (Doil et al.,
2009), mediating the recruitment of 53BP1, which in turn pro-
motes telomere fusions. At mammalian telomeres, RNF8 acts on
multiple targets. Besides playing a key role in mediating telomeric
DDR, evidenced by its accumulation at uncapped telomeres and
by favoring telomere fusions (Peuscher and Jacobs, 2011), RNF8
counteracts telomere dysfunction by binding and stabilizing TPP1
at telomeres (Rai et al., 2011). The recruitment of RNF168 is inhib-
ited by the activities of the deubiquitinating enzyme BRCC3,which
counteract the action of RNF8, and of the ubiquitin ligase UBR5,
which targets RNF168 for degradation. At telomeres, these two
enzymes are recruited by TRF2 through the C-terminal region of
the hinge domain, named inhibitor of DDR (iDDR) (Okamoto
et al., 2013).
The DNA damage signaling consequent to telomere shortening
seems to cause a global chromatin change. Upon aging of human
fibroblasts, the synthesis of histones decreases, as well as the syn-
thesis of the histone chaperones ASF1 and CAF1, and of stem loop
binding protein (SLBP), a stabilizer of histone mRNA (O’Sullivan
et al., 2010). Moreover, the global and the telomere-specific dis-
tribution of histone marks throughout the cell cycle are altered
as a consequence of cellular aging. Re-activation of telomerase is
sufficient to revert these changes (O’Sullivan et al., 2010).
CROSSTALK BETWEEN SHELTERIN, HISTONES, AND TERRA
AT TELOMERES
In the dynamic change from a protected to a deprotected telomeric
state, a relevant issue concerns the interplay between the actors
present at telomeres. Telomere shortening causes a reduction in
telomeric repeats; therefore, it is easy to predict an increased
competition between TRF1, TRF2, and the histone octamer for
binding to telomeric DNA. Little is known about the relative abun-
dance of these proteins at telomeres and whether it varies with
changes in telomere length. De Lange and coworkers measured
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the stoichiometry of the six proteins forming the shelterin com-
plex in different human cell lines (Takai et al., 2010). Assuming
that all the shelterin proteins in the chromatin-bound fraction are
associated with telomeres, the authors estimated their abundance
at telomeres. Although the absolute number of chromatin-bound
molecules seems variable and independent from telomere length,
the densities of TRF1 and TRF2 increase at short telomeres (Takai
et al., 2010) and their abundance is sufficient to saturate the entire
telomeres. However, TRF1 and TRF2 have to recognize their bind-
ing sites in a dense nucleosomal context. Even if a measurement of
histone absolute density at telomeres is lacking, data from MNase
digestions (Lejnine et al., 1995; Wu and de Lange, 2008) and elec-
tron microscopy analyses (Nikitina and Woodcock, 2004) indicate
that telomeres are organized in a tight nucleosomal array for most
of their length. Therefore, it is likely that the structure of telom-
eric chromatin derives from the interplay between TRF proteins
and nucleosomes. In vitro studies showed that telomeric proteins
such as yeast Rap1 (Rossetti et al., 2001) and human TRF1 (Galati
et al., 2006) are able to recognize their binding sites in a nucleoso-
mal context. Nucleosome stability is not affected by the addition
of TRF1, even at saturating concentration (Galati et al., 2006);
however, TRF1 has the ability to remodel nucleosomes inducing
their sliding toward adjacent sequences (Pisano et al., 2010). Other
studies examined how TRF2 interacts with telomeric chromatin.
Addition of TRF2 to in vitro reconstituted telomeric nucleosomal
arrays induces their compaction (Baker et al., 2011), whereas TRF1
ability to condense DNA seems inhibited by its acidic N-terminal
domain (Poulet et al., 2012). Contrary to this, when added to an
in vitro chromatin assembly system containing ATP-dependent
chromatin remodelers, TRF2 causes nucleosome remodeling by
increasing telomeric nucleosomal spacing (Galati et al., 2012).
The relationship between telomeric proteins and telomeric nucle-
osomes has been studied also in vivo by altering the expression of
shelterin proteins. Deletion of TRF2 or POT1 in mouse embry-
onic fibroblasts (MEF) leads to telomere deprotection but does
not result in any evident alteration of the nucleosomal organiza-
tion as detected by MNase mapping (Wu and de Lange, 2008).
Even depletion of the whole shelterin complex from MEF telom-
eres does not lead to changes in the MNase profile (Sfeir and de
Lange, 2012). These data indicate that the basic organization of
telomeric chromatin consists of shortly spaced nucleosomes both
in the proximal and in the distal part of telomeres. A different
conclusion emerges from a recent paper, in which TRF2 removal
from telomeres induced by overexpression of a dominant negative
mutant (TRF2∆B∆M) resulted in an increase of histone density at
telomeres, as evidenced by ChIP experiments (Galati et al., 2012).
The latter result could either derive from an increased accessibil-
ity of nucleosomes to anti-histone antibodies in the absence of
TRF2 or to the existence of nucleosome-free regions at telomeres
not detectable by MNase mapping. Furthermore, it must be con-
sidered that telomere structure could be differently organized in
the cellular systems used, respectively mouse cells with very long
telomeres (about 30 kbp) and human cancer cells with relatively
short telomeres (about 7–8 kbp).
The ability of TRF2 to regulate nucleosomal organization at
telomeres emerges from experiments in which TRF2 is overex-
pressed. In mouse keratinocytes, overexpression of TRF2 caused
the increase of internucleosomal distance and reduced histone
density at telomeres (Benetti et al., 2008b). Enhanced TRF2 expres-
sion remodels telomeric nucleosome organization also in human
cells from cervix carcinoma and from immortalized fibroblasts,
resulting in higher histone density at telomeres along with DNA
replication and in increased spacing of telomeric nucleosomes
(Galati et al., 2012).
Even if its precise function in telomere regulation remains
largely unknown, the interplay of TERRA RNA with telomeric
proteins and telomeric chromatin is likely to play an impor-
tant role. TERRA has been shown to bind directly to TRF1
and TRF2, facilitating the recruitment at telomeres of the hete-
rochromatic proteins ORC (origin recognition protein) and HP1;
siRNA depletion of TERRA causes a reduction of heterochro-
matic marks at telomeres inducing telomere dysfunction (Deng
et al., 2009b). In addition, TERRA binding reduces TRF2 ability
to condense telomeric DNA (Poulet et al., 2012). Conversely, het-
erochromatic state influences TERRA expression levels. TERRA
transcription depends on subtelomeric DNA methylation (Ner-
gadze et al., 2009), and also on the histone H3K4 methyltransferase
MLL (Caslini et al., 2009). Finally, TERRA seems to have a role in
the protection of the single-stranded chromosome end by mod-
ulating POT1 and RPA1 binding through its interaction with the
heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) (Flynn
et al., 2011).
CONCLUSION
One of the main unresolved issues in telomere biology concerns
the structural changes involved in the switch from a protected to
a deprotected state as telomeres shorten. The shelterin complex
protects telomeres from the DDR response inhibiting six signal-
ing and repair pathways (Sfeir and de Lange, 2012). Although the
generation of ATM-dependent or ATR-dependent DDR at telom-
eres can be essentially attributed to shelterin removal, there could
be different outcomes. The acute deprotection derived from the
depletion of shelterin proteins such as TRF2 or POT1 leads to
extensive telomere fusions. Instead, the DDR to telomere shorten-
ing in human cells is a regulated process resulting in p53-mediated
cell cycle arrest and entry in replicative senescence. To explain
these differences, a three-state model of telomere protection has
been proposed (Cesare et al., 2009; Cesare and Karlseder, 2012).
In this model, telomere protection is assured by a closed state
characterized by a yet undefined structure that might be rep-
resented by the t-loop. Telomere shortening could disrupt this
structure leading to an intermediate state recognized as DNA
damage, but that retains enough shelterin proteins (particularly
TRF2) to prevent NHEJ and thus fusion of chromosome ends.
Further shortening results in a fully uncapped state in which the
levels of bound shelterin are insufficient to impede end-to-end
fusions. Recent observations are consistent with this model. The
study of spontaneous telomere deprotection in human primary
cells showed that the establishment of DDR at about five telom-
eres in the absence of end-to-end fusions is required to induce
p53-dependent senescence (Kaul et al., 2012). In agreement with
the existence of an intermediate state, the analysis of individual
telomeres showed that TIFs co-localize with TRF2 and telomeric
DNA signals. In addition, the inhibition of p53 leads to senescence
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bypass and to the appearance of telomere fusions characteristic
of a fully uncapped state (Kaul et al., 2012). Further support
comes from the observation that DNA damage induced by ion-
izing radiation in senescent cells is repaired by end-joining at
genomic sites but not at telomeres, indicating that TRF2 retains
the capacity to prevent NHEJ at telomeres (Fumagalli et al., 2012;
Hewitt et al., 2012). Finally, it has been recently shown that the
repression of ATM signaling and of NHEJ by TRF2 depends on
two different domains of the protein (Okamoto et al., 2013).
Using a set of mutant proteins in which TRF2 domains were
replaced by the analogous TRF1 domains, the authors demon-
strated that the ATM pathway is inhibited by the dimerization
domain TRFH, whereas NHEJ repression depends on the C-
terminal region of the hinge domain, iDDR, which acts by inhibit-
ing the ubiquitin ligase RNF168, necessary for the recruitment
of 53BP1.
In this context, it is worth recalling that cell fate is linked to
the stochastic probability of single telomeres to become depro-
tected (Blackburn, 2000). DNA damage signaling can be found
also at long telomeres, although less frequently that at short telom-
eres (Kaul et al., 2012); in addition, a single deprotected telomere
is not sufficient to trigger cell growth arrest, indicating that it
might revert to a closed protected state. Indeed, this occurs at
every cell cycle: during the S-phase the passage of the replication
fork disrupts the closed telomere structure, leading to chromatin
rearrangements and to the recruitment of DNA damage factors at
telomeres during G2 phase (Verdun et al., 2005). Therefore, in a
pre-senescent state, telomeres might switch between a protected
and a deprotected state (Figure 1). Telomere erosion eventually
shifts the equilibrium toward the deprotected state, leading to
cell cycle arrest in G1 and therefore to replicative senescence.
Further shortening – for example bypassing growth arrest check-
point as a result of p53/RB inactivation – irreversibly gives rise
to a fully dysfunctional state culminating in telomere fusions and
crisis.
Increasing data are accumulating in support of a role for his-
tone modifications, histone variants, chromatin remodeling com-
plexes and histone chaperones involved in telomere functions and
dynamics. Figure 2 summarizes the still incomplete pattern of his-
tone modifications associated with the transition from a protected
to a deprotected state and with a fully dysfunctional state. Telom-
ere shortening and the consequent deprotection seem associated
with a reduction of heterochromatic marks at telomeres, such as
a decrease of H3K9me3 and an increase of acetylated residues.
Telomere deprotection and the full uncapping consequent to fur-
ther shortening are signaled by phosphorylation of H2AX and the
ubiquitylation of H2A and H2AX. At present, a clear understand-
ing of the precise timing of appearance of histone modifications
and of their functional significance is still lacking. Furthermore, a
bias in evaluating the role of histone modifications in the establish-
ment of a protective state at telomeres could derive from the fact
that most data on the epigenetic status of telomeres and on telom-
ere deprotection come from studies on murine cells. Lab mice have
long telomeres (40–60 kbp) compared to humans (4–15 kbp) and
do not undergo cell senescence due to telomere erosion (Itahana
et al., 2004; Henriques and Ferreira, 2012). Therefore, extrapolat-
ing the data obtained in mice to human telomere could lead to
incorrect conclusions.
It seems interesting to highlight that one of the main conse-
quences of nucleosomal organization is to limit the accessibility
of telomeric proteins to their binding sites. Both short and long
telomeres seem to share the same tight nucleosomal organization
that hinders most of the binding sites for TRF1 and TRF2. TRF1 is
able to bind quite efficiently also to telomeric repeats on the nucle-
osome (Galati et al., 2006), whereas the binding of TRF2 at telom-
eres seems much more hindered by the presence of nucleosomes
(Pisano et al., 2008). These differences could partly be attributed
to the different N-terminal domains of the two proteins, acidic in
the case of TRF1, basic for TRF2; it has recently been proposed
that these domains play an important role in regulating telom-
eric chromatin compaction (Poulet et al., 2012). TRF1 and TRF2
binding in a nucleosomal context could be affected by histone
modifications. For example, acetylation of lysine residues reduces
the positive charge of histones, increasing the accessibility of nucle-
osomal DNA to binding proteins (Lee et al., 1993). On the other
side, bulky modifications such as ubiquitylation might represent
FIGURE 1 |Telomere state determines cell destiny. Telomeres
swing between a protected and a deprotected state throughout the
cell cycle. Accumulation of more than five deprotected telomeres is
sufficient to induce replicative senescence. The inactivation of
p53/RB signaling pathways allows escaping the growth arrest
checkpoint; the consequent further shortening leads to loss of the
remaining shelterin and to a dysfunctional state that activates the
DNA repair machinery.
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FIGURE 2 | Graphical representation of the different telomere states,
characterized by different levels of telomeric proteins and
post-translational modifications. Protected state: telomere is in a closed
form, probably the t-loop, maintained by the binding with the shelterin
proteins; the presence of trimethylation of histones H3 and H4, typical
heterochromatic markers, induces a compacted state. This state inhibits the
DNA damage response. Deprotected state: telomere shortening could
disrupt the closed structure leading to an open state, characterized by a
decrease of heterochromatic marks. Telomeres are recognized as DNA
damage, signaled by phosphorylation of H2AX, but retain enough shelterin
proteins (mainly TRF2) to prevent NHEJ and thus telomeric fusion. DNA
damage signaling leads to replicative senescence. Dysfunctional state: if
growth arrest checkpoint is inactivated, telomeres continue to shorten
leading to a fully uncapped form, deriving from the depletion of shelterin
proteins such as TRF2 or POT1. Telomere dysfunctions are signaled by
phosphorylation of H2AX and the ubiquitylation of H2A and H2AX.
Telomeres are not protected from the DNA damage response machinery,
giving rise to extensive telomere fusions.
a steric hindrance for the binding of TRF proteins in a nucleoso-
mal context. Therefore, the modifications of histones related with
telomere shortening could alter the binding equilibrium of TRF
proteins and consequently telomere protection.
The establishment of a mechanism of telomere maintenance
is a key factor in the acquisition of the unlimited proliferative
capacity of cancer cells (Hanahan and Weinberg, 2011). In this
regard, a deeper knowledge of the mechanisms and the struc-
tural determinants that regulate telomere stability and control the
entry in replicative senescence represents a major goal not only in
basic research but also for the implications in the development of
anticancer therapies.
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